Trials / Completed
CompletedNCT07066865
Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease
Safety and Efficacy of Sutureless Dehydrated Amniotic Membrane (Omnigen) Mounted on Contact Lens (Omnilenz) for Ttt of Ocular Graft vs Host Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Farwaniya Hospital · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A case series of patients presented with graft versus host disease with ocular involvement . The study recruited a total of 3 patients who were referred to cornea clinic of Farwaniya Hospital, Kuwait between April 2022 and April 2024. All cases presented with severe dryness, spks and corneal epithelial defect not responding to other measures of treatment. An OmniLenz was applied for each patient for one week. Primary outcome measures included healing of the corneal resistant epithelial defect, secondary outcome measures were improvement of signs of dryness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | omniLenz | sutureless dehydrated amniotic membrane (omnigen) mounted on contact lens (omnilenz) |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
- First posted
- 2025-07-15
- Last updated
- 2025-07-15
Locations
1 site across 1 country: Kuwait
Source: ClinicalTrials.gov record NCT07066865. Inclusion in this directory is not an endorsement.